vs
Apellis Pharmaceuticals, Inc.（APLS）与CENTRUS ENERGY CORP（LEU）财务数据对比。点击上方公司名可切换其他公司
Apellis Pharmaceuticals, Inc.的季度营收约是CENTRUS ENERGY CORP的1.4倍（$199.9M vs $146.2M），CENTRUS ENERGY CORP同比增速更快（-3.6% vs -5.9%），Apellis Pharmaceuticals, Inc.自由现金流更多（$-14.3M vs $-58.0M），过去两年CENTRUS ENERGY CORP的营收复合增速更高（82.9% vs 7.7%）
Apellis Pharmaceuticals是一家临床阶段生物制药企业，专注于开发调节补体系统的靶向疗法，适应症覆盖年龄相关性黄斑变性继发地图样萎缩等眼科疾病、罕见血液病及自身免疫性疾病，核心市场为美国及欧盟地区。
Centrus Energy Corp是美国能源企业，主营核电站所需核燃料供应，同时专注于离心技术的研发与落地推广，生产可应用于商业、政府场景及国家安全领域的浓缩铀产品。
APLS vs LEU — 直观对比
营收规模更大
APLS
是对方的1.4倍
$146.2M
营收增速更快
LEU
高出2.4%
-5.9%
自由现金流更多
APLS
多$43.7M
$-58.0M
两年增速更快
LEU
近两年复合增速
7.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $199.9M | $146.2M |
| 净利润 | $-59.0M | — |
| 毛利率 | — | 23.9% |
| 营业利润率 | -25.6% | 8.8% |
| 净利率 | -29.5% | — |
| 营收同比 | -5.9% | -3.6% |
| 净利润同比 | -62.2% | — |
| 每股收益（稀释后） | $-0.40 | $0.52 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收APLSLEU
| Q4 25 | $199.9M | $146.2M | ||
| Q3 25 | $458.6M | $74.9M | ||
| Q2 25 | $178.5M | $154.5M | ||
| Q1 25 | $166.8M | $73.1M | ||
| Q4 24 | $212.5M | $151.6M | ||
| Q3 24 | $196.8M | $57.7M | ||
| Q2 24 | $199.7M | $189.0M | ||
| Q1 24 | $172.3M | $43.7M |
净利润APLSLEU
| Q4 25 | $-59.0M | — | ||
| Q3 25 | $215.7M | $3.9M | ||
| Q2 25 | $-42.2M | $28.9M | ||
| Q1 25 | $-92.2M | $27.2M | ||
| Q4 24 | $-36.4M | — | ||
| Q3 24 | $-57.4M | $-5.0M | ||
| Q2 24 | $-37.7M | $30.6M | ||
| Q1 24 | $-66.4M | $-6.1M |
毛利率APLSLEU
| Q4 25 | — | 23.9% | ||
| Q3 25 | — | -5.7% | ||
| Q2 25 | — | 34.9% | ||
| Q1 25 | — | 45.0% | ||
| Q4 24 | — | 40.8% | ||
| Q3 24 | — | 15.4% | ||
| Q2 24 | — | 19.3% | ||
| Q1 24 | — | 9.8% |
营业利润率APLSLEU
| Q4 25 | -25.6% | 8.8% | ||
| Q3 25 | 48.7% | -22.2% | ||
| Q2 25 | -18.6% | 21.7% | ||
| Q1 25 | -50.0% | 28.0% | ||
| Q4 24 | -12.3% | 29.7% | ||
| Q3 24 | -24.0% | -13.2% | ||
| Q2 24 | -14.7% | 11.2% | ||
| Q1 24 | -36.0% | -24.3% |
净利率APLSLEU
| Q4 25 | -29.5% | — | ||
| Q3 25 | 47.0% | 5.2% | ||
| Q2 25 | -23.6% | 18.7% | ||
| Q1 25 | -55.3% | 37.2% | ||
| Q4 24 | -17.1% | — | ||
| Q3 24 | -29.2% | -8.7% | ||
| Q2 24 | -18.9% | 16.2% | ||
| Q1 24 | -38.5% | -14.0% |
每股收益（稀释后）APLSLEU
| Q4 25 | $-0.40 | $0.52 | ||
| Q3 25 | $1.67 | $0.19 | ||
| Q2 25 | $-0.33 | $1.59 | ||
| Q1 25 | $-0.74 | $1.60 | ||
| Q4 24 | $-0.30 | $3.26 | ||
| Q3 24 | $-0.46 | $-0.30 | ||
| Q2 24 | $-0.30 | $1.89 | ||
| Q1 24 | $-0.54 | $-0.38 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $466.2M | $2.0B |
| 总债务越低越好 | — | $1.2B |
| 股东权益账面价值 | $370.1M | $765.1M |
| 总资产 | $1.1B | $2.4B |
| 负债/权益比越低杠杆越低 | — | 1.54× |
8季度趋势，按日历期对齐
现金及短期投资APLSLEU
| Q4 25 | $466.2M | $2.0B | ||
| Q3 25 | $479.2M | $1.6B | ||
| Q2 25 | $370.0M | $833.0M | ||
| Q1 25 | $358.4M | $653.0M | ||
| Q4 24 | $411.3M | $671.4M | ||
| Q3 24 | $396.9M | $194.3M | ||
| Q2 24 | $360.1M | $227.0M | ||
| Q1 24 | $325.9M | $209.3M |
总债务APLSLEU
| Q4 25 | — | $1.2B | ||
| Q3 25 | — | $1.2B | ||
| Q2 25 | — | $390.0M | ||
| Q1 25 | — | $389.5M | ||
| Q4 24 | — | $472.5M | ||
| Q3 24 | — | $83.5M | ||
| Q2 24 | — | $86.5M | ||
| Q1 24 | $93.1M | $86.5M |
股东权益APLSLEU
| Q4 25 | $370.1M | $765.1M | ||
| Q3 25 | $401.2M | $363.1M | ||
| Q2 25 | $156.3M | $359.1M | ||
| Q1 25 | $164.2M | $213.9M | ||
| Q4 24 | $228.5M | $161.4M | ||
| Q3 24 | $237.1M | $76.4M | ||
| Q2 24 | $264.3M | $76.6M | ||
| Q1 24 | $266.7M | $33.8M |
总资产APLSLEU
| Q4 25 | $1.1B | $2.4B | ||
| Q3 25 | $1.1B | $2.2B | ||
| Q2 25 | $821.4M | $1.3B | ||
| Q1 25 | $807.3M | $1.3B | ||
| Q4 24 | $885.1M | $1.1B | ||
| Q3 24 | $901.9M | $591.0M | ||
| Q2 24 | $904.5M | $668.2M | ||
| Q1 24 | $831.9M | $750.0M |
负债/权益比APLSLEU
| Q4 25 | — | 1.54× | ||
| Q3 25 | — | 3.23× | ||
| Q2 25 | — | 1.09× | ||
| Q1 25 | — | 1.82× | ||
| Q4 24 | — | 2.93× | ||
| Q3 24 | — | 1.09× | ||
| Q2 24 | — | 1.13× | ||
| Q1 24 | 0.35× | 2.56× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-14.2M | $-48.4M |
| 自由现金流经营现金流 - 资本支出 | $-14.3M | $-58.0M |
| 自由现金流率自由现金流/营收 | -7.1% | -39.7% |
| 资本支出强度资本支出/营收 | 0.1% | 6.6% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $45.0M | $31.3M |
8季度趋势，按日历期对齐
经营现金流APLSLEU
| Q4 25 | $-14.2M | $-48.4M | ||
| Q3 25 | $108.5M | $10.1M | ||
| Q2 25 | $4.4M | $52.8M | ||
| Q1 25 | $-53.4M | $36.5M | ||
| Q4 24 | $19.4M | $57.9M | ||
| Q3 24 | $34.1M | $-33.2M | ||
| Q2 24 | $-8.3M | $7.0M | ||
| Q1 24 | $-133.0M | $5.3M |
自由现金流APLSLEU
| Q4 25 | $-14.3M | $-58.0M | ||
| Q3 25 | $108.3M | $5.7M | ||
| Q2 25 | $4.4M | $49.2M | ||
| Q1 25 | $-53.4M | $34.4M | ||
| Q4 24 | $19.3M | $57.2M | ||
| Q3 24 | — | $-34.2M | ||
| Q2 24 | $-8.4M | $6.1M | ||
| Q1 24 | $-133.3M | $3.8M |
自由现金流率APLSLEU
| Q4 25 | -7.1% | -39.7% | ||
| Q3 25 | 23.6% | 7.6% | ||
| Q2 25 | 2.5% | 31.8% | ||
| Q1 25 | -32.0% | 47.1% | ||
| Q4 24 | 9.1% | 37.7% | ||
| Q3 24 | — | -59.3% | ||
| Q2 24 | -4.2% | 3.2% | ||
| Q1 24 | -77.3% | 8.7% |
资本支出强度APLSLEU
| Q4 25 | 0.1% | 6.6% | ||
| Q3 25 | 0.0% | 5.9% | ||
| Q2 25 | 0.0% | 2.3% | ||
| Q1 25 | 0.0% | 2.9% | ||
| Q4 24 | 0.0% | 0.5% | ||
| Q3 24 | 0.0% | 1.7% | ||
| Q2 24 | 0.0% | 0.5% | ||
| Q1 24 | 0.2% | 3.4% |
现金转化率APLSLEU
| Q4 25 | — | — | ||
| Q3 25 | 0.50× | 2.59× | ||
| Q2 25 | — | 1.83× | ||
| Q1 25 | — | 1.34× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 0.23× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
APLS
| Syfovre | $155.2M | 78% |
| Empaveli Pegcetacoplan | $35.1M | 18% |
| Licensing And Other Revenue | $9.6M | 5% |
LEU
| Separative Work Units | $111.0M | 76% |
| Services | $21.8M | 15% |
| Other | $13.4M | 9% |
